A clinical decision begins with your history
A first appointment should cover the reason for treatment, previous approaches, medical history, current medicines and what you hope to improve. Prescription weight-management medicine is one part of care alongside nutrition and physical activity. An online assessment or an appealing advertisement does not establish that a particular drug is appropriate.
Ask the clinician to explain the labeled indication and how your history fits it. Weight-management and diabetes brands can share an ingredient while having different approved uses. If the clinician proposes a different route or a compounded preparation, ask why it is needed and what evidence applies to that exact product.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK · Wegovy prescribing information · Zepbound prescribing information
Bring the full medicine and health picture
Include prescriptions, supplements, allergies, pregnancy plans, previous gastrointestinal problems and any upcoming surgery or procedure. The labels cover contraindications and important precautions, including a personal or family history of medullary thyroid carcinoma (MTC), MEN 2, serious product allergies and interactions with certain other medicines. This does not mean every thyroid disorder is a contraindication. A qualified clinician needs that information before choosing and dosing treatment.
Discuss how symptoms will be managed and who to contact after hours. Insulin or insulin-secretagogue treatment can change hypoglycemia risk and may need review. Do not stop another medicine or choose an escalation schedule on your own.
Sources: Wegovy prescribing information · Zepbound prescribing information · Foundayo prescribing information
Pregnancy and contraception instructions differ
For weight management, Wegovy should be discontinued when pregnancy is recognized, and its label specifies stopping at least two months before a planned pregnancy. Zepbound and Foundayo also call for discontinuation when pregnancy is recognized. Discuss your plans before starting and contact the prescriber promptly if you become pregnant.
Tirzepatide can reduce the effectiveness of oral hormonal contraceptives. The Zepbound label advises a non-oral method or an added barrier method for four weeks after starting and after each dose increase. Foundayo uses 30 days after starting and after each increase. Do not assume every GLP-1 medicine uses the same rule. Breastfeeding advice is also product-specific; Wegovy tablets and Foundayo are not recommended during breastfeeding.
Sources: Wegovy prescribing information · Zepbound prescribing information · Foundayo prescribing information
Discuss the practical routine
Current choices include weekly injections and approved daily oral options. Wegovy tablets require morning fasting and a waiting period; Foundayo has different administration and interaction instructions. Your ability to follow the actual routine is part of the decision.
Ask how refills, missed doses, travel and a prolonged interruption will be handled. Make sure the dispensing pharmacist can demonstrate the device or explain the tablet instructions. For a vial, ask for the concentration and exact dose measurement.
Sources: Wegovy prescribing information · Zepbound prescribing information · Foundayo prescribing information · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA
Make the long-term and financial plan visible
Ask what treatment success would mean beyond a scale number and when the clinician would reassess benefit and tolerability. NIDDK describes weight-management medicine as potentially long-term treatment; stopping can be followed by weight regain. Discuss continuation before treating the first month as a complete plan.
Separate medication from care, labs, supplies and shipping. Get the first charge, anticipated maintenance cost and renewal commitment in writing. This historical page replaces a fictional decision story with questions a real patient can use.
Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK